Pages that link to "Q44755697"
Jump to navigation
Jump to search
The following pages link to Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study (Q44755697):
Displayed 50 items.
- Secukinumab for rheumatology: development and its potential place in therapy (Q26738523) (← links)
- Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of Arthritis (Q26768254) (← links)
- Targeting Th17 Cells with Small Molecules and Small Interference RNA (Q26770523) (← links)
- Profile of secukinumab in the treatment of psoriasis: current perspectives (Q26776303) (← links)
- Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now? (Q26800154) (← links)
- Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity (Q26863295) (← links)
- Review: The interleukin-23/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond (Q26991709) (← links)
- Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease (Q27687830) (← links)
- Understanding Immune Cells in Tertiary Lymphoid Organ Development: It Is All Starting to Come Together (Q28067648) (← links)
- Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases (Q28076496) (← links)
- Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications (Q30699740) (← links)
- Future therapeutic targets in rheumatoid arthritis? (Q33841419) (← links)
- Clinical associations of serum interleukin-17 in systemic lupus erythematosus (Q34365880) (← links)
- Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2014 MauiDerm Meeting (Q34377347) (← links)
- Divergent gene activation in peripheral blood and tissues of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis following infliximab therapy (Q34380190) (← links)
- Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis (Q35164919) (← links)
- Central role of IL-17/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosis (Q35276739) (← links)
- Low baseline interleukin-17A levels are associated with better treatment response at 12 weeks to tocilizumab therapy in rheumatoid arthritis patients (Q35438412) (← links)
- Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis (Q35834582) (← links)
- T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity (Q35836112) (← links)
- Basic biology and role of interleukin-17 in immunity and inflammation (Q35932948) (← links)
- Pathogenic Transdifferentiation of Th17 Cells Contribute to Perpetuation of Rheumatoid Arthritis during Anti-TNF Treatment (Q36167063) (← links)
- Higher efficacy of anti-IL-6/IL-21 combination therapy compared to monotherapy in the induction phase of Th17-driven experimental arthritis (Q36270103) (← links)
- Secukinumab. (Q36391509) (← links)
- Serum Levels of IL-6 and TNF-α May Correlate with Activity and Severity of Rheumatoid Arthritis (Q36412824) (← links)
- Prostaglandin E2-EP4 signaling persistently amplifies CD40-mediated induction of IL-23 p19 expression through canonical and non-canonical NF-κB pathways. (Q36674441) (← links)
- The pathogenic role of angiogenesis in rheumatoid arthritis (Q36934777) (← links)
- Ratio of Circulating IFNγ (+) "Th17 Cells" in Memory Th Cells Is Inversely Correlated with the Titer of Anti-CCP Antibodies in Early-Onset Rheumatoid Arthritis Patients Based on Flow Cytometry Methods of the Human Immunology Project (Q36936735) (← links)
- Secukinumab, a novel anti-IL-17A antibody, shows low immunogenicity potential in human in vitro assays comparable to other marketed biotherapeutics with low clinical immunogenicity (Q37138974) (← links)
- Efficacy and safety of monoclonal antibodies targeting interleukin-17 pathway for inflammatory arthritis: a meta-analysis of randomized controlled clinical trials (Q37258941) (← links)
- Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage (Q37340305) (← links)
- 17 and 23: prime numbers for ankylosing spondylitis? (Q37378175) (← links)
- Th17-associated cytokines as a therapeutic target for steroid-insensitive asthma (Q37456949) (← links)
- Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis (Q37460263) (← links)
- Analysis of CXCR5+Th17 cells in relation to disease activity and TNF inhibitor therapy in Rheumatoid Arthritis (Q37526168) (← links)
- Immunopathogenesis of granulomas in chronic autoinflammatory diseases (Q37538526) (← links)
- The inflammatory role of phagocyte apoptotic pathways in rheumatic diseases. (Q37631369) (← links)
- Th17 and CD24hiCD27+ regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis (Q37635190) (← links)
- Mechanistic rationales for targeting interleukin-17A in spondyloarthritis (Q37686009) (← links)
- A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis (Q37691163) (← links)
- Novel mechanisms of action of the biologicals in rheumatic diseases. (Q38076350) (← links)
- Newest clinical trial results with antitumor necrosis factor and nonantitumor necrosis factor biologics for rheumatoid arthritis (Q38091288) (← links)
- Monoclonal antibody treatments for rheumatoid arthritis (Q38116065) (← links)
- Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis (Q38118781) (← links)
- Emerging cell and cytokine targets in rheumatoid arthritis (Q38161794) (← links)
- Diagnosing and treating psoriatic arthritis: an update (Q38165235) (← links)
- Emerging immunotherapies for rheumatoid arthritis. (Q38188862) (← links)
- Novel monoclonal antibodies for therapy of multiple sclerosis (Q38191996) (← links)
- Advances in treating psoriasis (Q38193099) (← links)
- The role of interleukin-17A in psoriatic disease (Q38217029) (← links)